Dube Michael P

EDGAR CIK 0002019493

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
VP, Chief Accounting Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($54,959)
-3,384 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/03/2025
01/07/2025
Sell
-1,372 @ $12.18
 ($16,711) 45,640 (-2.92%) Direct
10/02/2024
10/04/2024
Sell
-2,012 @ $19.01
 ($38,248) 47,012 (-4.10%) Direct